Latest Data & Signals Issued

Signal Type Signal Value Data
Score -6.101 21 days ( 21.90 % )
Last Price $1.64 -4.09 %
High/ Low $1.62 - $1.74 -4.33%
Chg 7 Days -13.68 % $1.90 $1.64
Chg 30 Days -28.70 % $2.30 $1.64
Chg 12 mos 87.11 % $0.88 $1.64
Trend - 3 mos -10.91 % Width: 70.75 %
Trend - 12 mos 116.85 % Width: 129.96 %
Pred. range - 3 mos $1.40 - $2.39 -14.63 % - 45.76 %
Pred. range - 12 mos $3.19 - $7.35 94.77 % - 347.88 %
Short MA avg 3 mos Buy Jun 17, 2024 - 12 days
Long MA avg 3 mos Buy May 31, 2024 - 23 days
Short/Long MA avg 3 mos Sell Jun 04, 2024 - 21 days
Short MA avg 12 mos Sell May 24, 2024 - 27 days
Long MA avg 12 mos Sell Jun 27, 2024 - 5 days
Short/Long MA avg 12 mos Buy Jan 11, 2024 - 120 days
Pivot Short Sell Apr 12, 2024 - 57 days
Bollinger Buy Jun 04, 2024 - 21 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Entera Bio Ltd.

Entera Bio Ltd. Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials fo... ENTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT